Glutathione, macrophages and unstable atherosclerosis
Glutathione, macrophages and unstable atherosclerosis
批准号:
7221296
负责人:
MICHAEL E ROSENFELD
金额:
$35.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2009-03-31
关键词:
AntioxidantsApolipoprotein EArterial Fatty StreakAtherosclerosisBone Marrow Cell TransplantationCell DeathCellsCessation of lifeCholesterolCytoskeletonDataEnzymesGenesGlutamate-Cysteine LigaseGlutathioneHemorrhageIn VitroLesionLigase GeneLipoproteinsMusMyocardial InfarctionPlayProbabilityProtein OverexpressionRateReactive Oxygen SpeciesRegulationResistanceRoleRuptureStrokeTestingThrombosiscell typecytotoxicdesignhuman GCLC proteinhuman GCLM proteinkillingslow density lipoprotein inhibitormacrophageoxidized lipidoxidized low density lipoproteinprevent
中文摘要
描述(由申请人提供):动脉粥样硬化斑块内巨噬细胞的死亡可能在斑块转化为不稳定斑块(易破裂和出血)中起重要作用。目前还不清楚究竟是什么杀死了斑块内的巨噬细胞。一个可能的可能性是氧化脂质和游离胆固醇的积累,这些脂质和游离胆固醇来源于被细胞外基质捕获和保留的脂蛋白。体外巨噬细胞氧化LDL的积累伴随着谷胱甘肽的消耗,谷胱甘肽是大多数细胞类型的主要内源性抗氧化剂。谷胱甘肽合成的药理学刺激保护巨噬细胞免受氧化LDL的细胞毒性作用。我们的初步数据表明,谷氨酸半胱氨酸连接酶的催化亚基的过度表达,谷胱甘肽合成的限速酶也保护巨噬细胞免于因氧化LDL,氧化脂质部分和其他促氧化剂而死亡。氧化LDL也是谷氨酸半胱氨酸连接酶催化亚基和调节亚基表达的有效诱导剂。因此,我们假设,增加稳定表达的谷氨酸半胱氨酸连接酶在巨噬细胞将保护细胞从促氧化剂诱导的死亡,并增加动脉粥样硬化斑块的稳定性。为了验证这一假设,并进一步研究氧化脂质部分如何有助于调节巨噬细胞中谷氨酸半胱氨酸连接酶基因的表达,我们提出了以下三个具体目标。
1.探讨氧化型低密度脂蛋白(oxidized LDL,OLDL)氧化脂质组分对巨噬细胞谷氨酸半胱氨酸连接酶亚单位基因表达的调节作用。
2.研究GCL-c表达的增加是否以及如何抑制RAW细胞的促氧化剂和游离胆固醇诱导的死亡。
3.研究GCL-c过表达(谷胱甘肽生成能力增加)或GCL-m缺乏(谷胱甘肽生成能力降低)的骨髓细胞移植对老年apo E-1-小鼠巨噬细胞死亡和动脉粥样硬化的影响。
诸如本发明中包括的旨在防止巨噬细胞死亡的策略具有成功稳定动脉粥样硬化斑块的高概率,并且应该有助于减少斑块破裂、闭塞性血栓形成、心肌梗死和中风。
英文摘要
DESCRIPTION (provided by applicant): The death of macrophages within an atherosclerotic plaque may play a fundamental role in conversion of the plaque to an unstable plaque, one that is vulnerable to rupture and hemorrhage. It is currently unknown precisely what kills macrophages within the plaque. One likely possibility is accumulation of oxidized lipids and free cholesterol derived from lipoproteins that have been trapped and retained by the extra-cellular matrix. Accumulation of oxidized LDL by macrophages in vitro is accompanied by depletion of glutathione, the major endogenous antioxidant for most cell types. Pharmacological stimulation of glutathione synthesis protects macrophages from the cytotoxic effects of oxidized LDL. Our preliminary data suggests that overexpression of the catalytic subunit of glutamate cysteine ligase, the rate-limiting enzyme for glutathione synthesis also protects macrophages from death due to oxidized LDL, oxidized lipid moieties and other prooxidants. Oxidized LDL is also a potent inducer of the expression of both the catalytic and regulatory subunits of glutamate cysteine ligase. Thus, we hypothesize that increased stable expression of glutamate cysteine ligase in macrophages will protect the cells from pro-oxidant induced death and increase the stability of atherosclerotic plaques. To test this hypothesis and to further investigate how oxidized lipid moieties contribute to the regulation of expression of the glutamate cysteine ligase genes in macrophages, we propose the following three specific aims.
1.To determine the role of oxidized lipid components of oxidized LDL in the regulation of macrophage expression of the glutamate cysteine ligase subunit genes.
2.To determine whether ad how increased expression of GCL-c by RAW cells inhibits pro-oxidant and free cholesterol induced death.
3.To determine the effects of bone marrow transplantation of cells over-expressing GCL-c (increased capacity to make glutathione) or deficient in GCL-m (decreased capacity to make glutathione) on macrophage death and atherosclerosis in older apo E-l- mice with established lesions.
Strategies such as those included in the present proposal that are designed to prevent macrophage death have a high probability of successfully stabilizing atherosclerotic plaques and should help reduce plaque rupture, occlusive thrombosis, myocardial infarction and stroke.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.atherosclerosis.2008.06.017
发表时间:
2009-03
期刊:
ATHEROSCLEROSIS
影响因子:
5.3
作者:
[Averill, Michelle M., Bennett, Brian J., Rattazzi, Marcello, Rodmyre, Rebecca M., Kirk, Elizabeth A., Schwartz, Stephen M., Rosenfeld, Michael E.]
通讯作者:
Rosenfeld, Michael E.
RANK-RANKL and Vascular Complications in Chronic Kidney Disease
-
批准号:8699763
-
项目类别:
-
资助金额:$50.25万
-
财政年份:2012
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
RANK-RANKL and Vascular Complications in Chronic Kidney Disease
-
批准号:9096751
-
项目类别:
-
资助金额:$50.25万
-
财政年份:2012
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
RANK-RANKL and Vascular Complications in Chronic Kidney Disease
-
批准号:8369750
-
项目类别:
-
资助金额:$53.36万
-
财政年份:2012
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
RANK-RANKL and Vascular Complications in Chronic Kidney Disease
-
批准号:8529518
-
项目类别:
-
资助金额:$48.5万
-
财政年份:2012
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
2007 Atherosclerosis Gordon Research Conference
-
批准号:7271692
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2007
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
Glutathione, macrophages and unstable atherosclerosis
-
批准号:7030311
-
项目类别:
-
资助金额:$37.01万
-
财政年份:2004
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
Glutathione, macrophages and unstable atherosclerosis
-
批准号:6770595
-
项目类别:
-
资助金额:$36.35万
-
财政年份:2004
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
Diesel Exhaust and Atherosclerotic Plaque Stability
-
批准号:6941233
-
项目类别:
-
资助金额:$36.09万
-
财政年份:2004
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
Diesel Exhaust and Atherosclerotic Plaque Stability
-
批准号:6839894
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2004
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
Diesel Exhaust and Atherosclerotic Plaque Stability
-
批准号:7269408
-
项目类别:
-
资助金额:$34.22万
-
财政年份:2004
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
Diesel Exhaust and Atherosclerotic Plaque Stability
-
批准号:7102627
-
项目类别:
-
资助金额:$35.25万
-
财政年份:2004
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
Glutathione, macrophages and unstable atherosclerosis
-
批准号:6874349
-
项目类别:
-
资助金额:$37.9万
-
财政年份:2004
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
Diesel Exhaust and Atherosclerotic Plaque Stability
-
批准号:7037354
-
项目类别:
-
资助金额:$3.55万
-
财政年份:2004
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
C. Pneumoniae and atherosclerotic plaque destabilization
-
批准号:6771208
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2001
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
C. pneumoniae and atherosclerotic plaque destabilization
-
批准号:7535535
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2001
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
C. Pneumoniae and atherosclerotic plaque destabilization
-
批准号:6606178
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2001
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
C. pneumoniae and atherosclerotic plaque destabilization
-
批准号:7344744
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2001
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
C. pneumoniae and atherosclerotic plaque destabilization
-
批准号:7745440
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2001
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
C. Pneumoniae and atherosclerotic plaque destabilization
-
批准号:6369843
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2001
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
C. Pneumoniae and atherosclerotic plaque destabilization
-
批准号:6537917
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2001
-
负责人:MICHAEL E ROSENFELD
-
依托单位:
海外基金